ALZCHEM GROUP AG (ACT.DE) Fundamental Analysis & Valuation
FRA:ACT • DE000A2YNT30
Current stock price
174.1 EUR
-0.2 (-0.11%)
Last:
This ACT.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ACT.DE Profitability Analysis
1.1 Basic Checks
- ACT had positive earnings in the past year.
- In the past year ACT had a positive cash flow from operations.
- Each year in the past 5 years ACT has been profitable.
- Of the past 5 years ACT 4 years had a positive operating cash flow.
1.2 Ratios
- ACT's Return On Assets of 10.27% is amongst the best of the industry. ACT outperforms 91.67% of its industry peers.
- ACT has a Return On Equity of 24.76%. This is amongst the best in the industry. ACT outperforms 97.22% of its industry peers.
- ACT's Return On Invested Capital of 13.72% is amongst the best of the industry. ACT outperforms 93.06% of its industry peers.
- ACT had an Average Return On Invested Capital over the past 3 years of 13.60%. This is significantly above the industry average of 6.88%.
- The 3 year average ROIC (13.60%) for ACT is below the current ROIC(13.72%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.27% | ||
| ROE | 24.76% | ||
| ROIC | 13.72% |
ROA(3y)9.87%
ROA(5y)8.8%
ROE(3y)24.16%
ROE(5y)24.97%
ROIC(3y)13.6%
ROIC(5y)11.74%
1.3 Margins
- ACT has a better Profit Margin (11.29%) than 87.50% of its industry peers.
- In the last couple of years the Profit Margin of ACT has grown nicely.
- ACT's Operating Margin of 16.87% is amongst the best of the industry. ACT outperforms 86.11% of its industry peers.
- ACT's Operating Margin has improved in the last couple of years.
- ACT has a better Gross Margin (67.97%) than 97.22% of its industry peers.
- ACT's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.87% | ||
| PM (TTM) | 11.29% | ||
| GM | 67.97% |
OM growth 3Y35.88%
OM growth 5Y14.09%
PM growth 3Y26.76%
PM growth 5Y16.8%
GM growth 3Y11.38%
GM growth 5Y1.65%
2. ACT.DE Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ACT is creating value.
- ACT has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, ACT has less shares outstanding
- ACT has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 5.04 indicates that ACT is not in any danger for bankruptcy at the moment.
- ACT's Altman-Z score of 5.04 is amongst the best of the industry. ACT outperforms 88.89% of its industry peers.
- ACT has a debt to FCF ratio of 1.13. This is a very positive value and a sign of high solvency as it would only need 1.13 years to pay back of all of its debts.
- The Debt to FCF ratio of ACT (1.13) is better than 93.06% of its industry peers.
- ACT has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
- ACT has a Debt to Equity ratio of 0.14. This is in the better half of the industry: ACT outperforms 73.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | 1.13 | ||
| Altman-Z | 5.04 |
ROIC/WACC1.85
WACC7.41%
2.3 Liquidity
- A Current Ratio of 2.49 indicates that ACT has no problem at all paying its short term obligations.
- The Current ratio of ACT (2.49) is better than 77.78% of its industry peers.
- A Quick Ratio of 1.52 indicates that ACT should not have too much problems paying its short term obligations.
- ACT's Quick ratio of 1.52 is fine compared to the rest of the industry. ACT outperforms 72.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.49 | ||
| Quick Ratio | 1.52 |
3. ACT.DE Growth Analysis
3.1 Past
- ACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.57%, which is quite good.
- The Earnings Per Share has been growing by 26.48% on average over the past years. This is a very strong growth
- The Revenue has been growing slightly by 1.42% in the past year.
- The Revenue has been growing by 8.19% on average over the past years. This is quite good.
EPS 1Y (TTM)18.57%
EPS 3Y28.42%
EPS 5Y26.48%
EPS Q2Q%13.74%
Revenue 1Y (TTM)1.42%
Revenue growth 3Y1.21%
Revenue growth 5Y8.19%
Sales Q2Q%-1.26%
3.2 Future
- Based on estimates for the next years, ACT will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.17% on average per year.
- The Revenue is expected to grow by 10.68% on average over the next years. This is quite good.
EPS Next Y4.62%
EPS Next 2Y13.75%
EPS Next 3Y17.17%
EPS Next 5YN/A
Revenue Next Year4.79%
Revenue Next 2Y10.64%
Revenue Next 3Y11.58%
Revenue Next 5Y10.68%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. ACT.DE Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 27.63, ACT can be considered very expensive at the moment.
- Compared to the rest of the industry, the Price/Earnings ratio of ACT is on the same level as its industry peers.
- ACT's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.54.
- Based on the Price/Forward Earnings ratio of 27.07, the valuation of ACT can be described as expensive.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of ACT indicates a slightly more expensive valuation: ACT is more expensive than 62.50% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 21.68. ACT is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.63 | ||
| Fwd PE | 27.07 |
4.2 Price Multiples
- 65.28% of the companies in the same industry are cheaper than ACT, based on the Enterprise Value to EBITDA ratio.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACT is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 45.18 | ||
| EV/EBITDA | 14.38 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ACT does not grow enough to justify the current Price/Earnings ratio.
- The excellent profitability rating of ACT may justify a higher PE ratio.
- ACT's earnings are expected to grow with 17.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.98
PEG (5Y)1.04
EPS Next 2Y13.75%
EPS Next 3Y17.17%
5. ACT.DE Dividend Analysis
5.1 Amount
- ACT has a Yearly Dividend Yield of 1.20%.
- ACT's Dividend Yield is comparable with the industry average which is at 2.24.
- ACT's Dividend Yield is slightly below the S&P500 average, which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.2% |
5.2 History
- On average, the dividend of ACT grows each year by 19.13%, which is quite nice.
Dividend Growth(5Y)19.13%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
- ACT pays out 28.66% of its income as dividend. This is a sustainable payout ratio.
- ACT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.66%
EPS Next 2Y13.75%
EPS Next 3Y17.17%
ACT.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:ACT (4/29/2026, 5:36:15 PM)
174.1
-0.2 (-0.11%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Industry Strength53.38
Industry Growth36.67
Earnings (Last)02-27 2026-02-27/amc
Earnings (Next)04-30 2026-04-30
Inst Owners38.03%
Inst Owner ChangeN/A
Ins Owners28%
Ins Owner ChangeN/A
Market Cap1.77B
Revenue(TTM)562.12M
Net Income(TTM)63.46M
Analysts87.27
Price Target189.94 (9.1%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.2% |
Yearly Dividend1.79
Dividend Growth(5Y)19.13%
DP28.66%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.24%
PT rev (3m)5.24%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.86%
EPS NY rev (3m)-0.59%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.5%
Revenue NY rev (3m)-2.92%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.63 | ||
| Fwd PE | 27.07 | ||
| P/S | 3.15 | ||
| P/FCF | 45.18 | ||
| P/OCF | 12.94 | ||
| P/B | 6.92 | ||
| P/tB | 7.01 | ||
| EV/EBITDA | 14.38 |
EPS(TTM)6.3
EY3.62%
EPS(NY)6.43
Fwd EY3.69%
FCF(TTM)3.85
FCFY2.21%
OCF(TTM)13.46
OCFY7.73%
SpS55.22
BVpS25.18
TBVpS24.83
PEG (NY)5.98
PEG (5Y)1.04
Graham Number59.7392 (-65.69%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.27% | ||
| ROE | 24.76% | ||
| ROCE | 19.01% | ||
| ROIC | 13.72% | ||
| ROICexc | 16.03% | ||
| ROICexgc | 16.16% | ||
| OM | 16.87% | ||
| PM (TTM) | 11.29% | ||
| GM | 67.97% | ||
| FCFM | 6.98% |
ROA(3y)9.87%
ROA(5y)8.8%
ROE(3y)24.16%
ROE(5y)24.97%
ROIC(3y)13.6%
ROIC(5y)11.74%
ROICexc(3y)15.49%
ROICexc(5y)13.01%
ROICexgc(3y)15.65%
ROICexgc(5y)13.15%
ROCE(3y)18.84%
ROCE(5y)16.26%
ROICexgc growth 3Y18.84%
ROICexgc growth 5Y13.25%
ROICexc growth 3Y18.94%
ROICexc growth 5Y13.21%
OM growth 3Y35.88%
OM growth 5Y14.09%
PM growth 3Y26.76%
PM growth 5Y16.8%
GM growth 3Y11.38%
GM growth 5Y1.65%
F-Score7
Asset Turnover0.91
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | 1.13 | ||
| Debt/EBITDA | 0.3 | ||
| Cap/Depr | 366.97% | ||
| Cap/Sales | 17.4% | ||
| Interest Coverage | 54.63 | ||
| Cash Conversion | 112.78% | ||
| Profit Quality | 61.81% | ||
| Current Ratio | 2.49 | ||
| Quick Ratio | 1.52 | ||
| Altman-Z | 5.04 |
F-Score7
WACC7.41%
ROIC/WACC1.85
Cap/Depr(3y)203.37%
Cap/Depr(5y)168.11%
Cap/Sales(3y)9.66%
Cap/Sales(5y)8.22%
Profit Quality(3y)109.03%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.57%
EPS 3Y28.42%
EPS 5Y26.48%
EPS Q2Q%13.74%
EPS Next Y4.62%
EPS Next 2Y13.75%
EPS Next 3Y17.17%
EPS Next 5YN/A
Revenue 1Y (TTM)1.42%
Revenue growth 3Y1.21%
Revenue growth 5Y8.19%
Sales Q2Q%-1.26%
Revenue Next Year4.79%
Revenue Next 2Y10.64%
Revenue Next 3Y11.58%
Revenue Next 5Y10.68%
EBIT growth 1Y20.86%
EBIT growth 3Y37.52%
EBIT growth 5Y23.43%
EBIT Next Year45.19%
EBIT Next 3Y29.72%
EBIT Next 5Y22.18%
FCF growth 1Y-36.78%
FCF growth 3YN/A
FCF growth 5Y14.56%
OCF growth 1Y30.31%
OCF growth 3YN/A
OCF growth 5Y22.98%
ALZCHEM GROUP AG / ACT.DE Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for ALZCHEM GROUP AG?
ChartMill assigns a fundamental rating of 7 / 10 to ACT.DE.
What is the valuation status for ACT stock?
ChartMill assigns a valuation rating of 2 / 10 to ALZCHEM GROUP AG (ACT.DE). This can be considered as Overvalued.
What is the profitability of ACT stock?
ALZCHEM GROUP AG (ACT.DE) has a profitability rating of 9 / 10.
What is the valuation of ALZCHEM GROUP AG based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ALZCHEM GROUP AG (ACT.DE) is 27.63 and the Price/Book (PB) ratio is 6.92.
What is the earnings growth outlook for ALZCHEM GROUP AG?
The Earnings per Share (EPS) of ALZCHEM GROUP AG (ACT.DE) is expected to grow by 4.62% in the next year.